Uniphar (LSE:UPR) FFO


LSE:UPR Uniphar PLC LSE:UPR
84 GF Score
Price £3.93
GF Value £3.03
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Uniphar FFO?

FFO (Funds from operations) only applies to REITs.

LSE:UPR
84GF Score
Uniphar PLC LSE:UPR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Uniphar (LSE:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of £3.93 is trading 29.7% above its estimated GF Value™ of £3.03. GuruFocus considers Uniphar to be Modestly Overvalued.

Key valuation signals for LSE:UPR:

  • FFO:
  • GF Value™: £3.03 vs. price of £3.93 (29.7% above fair value)
  • GF Score™: 84/100 with 9 warning signs

No single metric tells the full story. See the LSE:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Uniphar Business Description

Other Exchanges UPR:Ireland0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
84GF Score

Get the complete analysis for LSE:UPR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£3.93
Price
£3.03
GF Value